Thromb Haemost 1975; 34(01): 324-325
DOI: 10.1055/s-0039-1689107
Abstracts
Schattauer GmbH

Pathobiology of Human Fibrinogen. Binding site for Staphylococci on Aα and Bβ chains of Fibrinogen Molecule

J. Hawiger
1   Vanderbilt University School of Medicine and VA Hospital, Nashville, TN. U.S.A.
,
D. K. Hammond
1   Vanderbilt University School of Medicine and VA Hospital, Nashville, TN. U.S.A.
,
S. Timmons
1   Vanderbilt University School of Medicine and VA Hospital, Nashville, TN. U.S.A.
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
22. Mai 2019 (online)

 

    The ability of human fibrinogen to interact with some staphylococci to cause a non-enzymatic clumping reaction has been used to detect fibrinogen and its derivates in blood and body fluids. We studied localization of the binding site for staphylococci on human fibrinogen using 125I-fibrinogen after reduction and alkylation of polypeptide chains, CNBr-treatment, and limited plasmin digestion. This combined approach revealed that the staphylococci-binding site is located on Aα and B β chains involving C-terminal portion but not N-terminal disulfide knot, γ chain has no binding site for staphylococci. Abnormal fibrinogens with defects in the N-terminal portion interacted normally with staphylococci. The degree of binding paralleled the extent of clumping reaction between staphylococci and 125I-fibrinogen or its plasminderived fragments. However, monomeric Scarboxymethyl Aα and B β chains showed a high degree of binding without concomitant clumping suggesting requirement for dimeric form of polypeptide chains for clumping. Conclusion: Aα and Bβ chains but not γ chain have homologous regions in terms of staphylococci-binding site on C-terminal portion responsible for clumping reaction. Thus, staphylococci can be used to measure abnormal fibrinogens with defects in the N-terminal region.

    (Supported by NIH Grants and VA.)